Welcome to our dedicated page for Guardian Pharmacy Services SEC filings (Ticker: GRDN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
It’s one thing to appreciate how Guardian Pharmacy Services, Inc. keeps assisted-living residents adherent to medication; it’s another to untangle the reimbursement footnotes, controlled-substance disclosures, and state-by-state regulations buried in SEC reports. Investors routinely spend hours locating pharmacy automation costs or Medicaid mix details, which is why searches like “Guardian Pharmacy Services insider trading Form 4 transactions” or “how to read the company’s 10-K” are so common.
Stock Titan’s AI solves that complexity. Our platform delivers Guardian Pharmacy Services quarterly earnings report 10-Q filing highlights, with segment revenue and technology spend distilled into plain language. Need governance data? The Guardian Pharmacy Services proxy statement executive compensation tables are cross-referenced against prior years. Real-time alerts surface Guardian Pharmacy Services Form 4 insider transactions real-time, so you never miss executive stock transactions Form 4. Sudden news is covered through Guardian Pharmacy Services 8-K material events explained, while bigger-picture trends appear in the Guardian Pharmacy Services annual report 10-K simplified. Every document streams from EDGAR the moment it’s posted, complete with AI-powered summaries that make Guardian Pharmacy Services SEC filings explained simply.
Whether you’re tracking margin pressures, comparing quarter-over-quarter adherence metrics, or timing trades around board activity, understanding Guardian Pharmacy Services SEC documents with AI saves hours. Dive into Guardian Pharmacy Services earnings report filing analysis, export numbers directly to your model, or monitor compliance flags—all in one place. From insider activity to cash-flow shifts, our comprehensive coverage equips professionals to act decisively.
John Ackerman, a director of Guardian Pharmacy Services, Inc. (GRDN), reported on Form 4 that on 09/27/2025 Class B common stock held indirectly by entities tied to him converted into Class A common stock in automatic tranches. The filing shows 1,413,940 Class B shares converting into Class A shares held by Pharmacy Investors, LLC, resulting in 1,863,564 Class A shares beneficially owned by that entity after the transaction. It also shows 471,057 Class B shares converting for Cardinal Equity Fund, L.P., yielding 620,851 Class A shares beneficially owned by that entity.
The conversion occurs pursuant to the company’s Amended and Restated Certificate of Incorporation, which provides one-for-one conversion of Class B to Class A in substantially equal tranches on 09/27/2025, 03/28/2026 and 09/27/2026. The Form 4 was signed by an attorney-in-fact on 09/30/2025.
Form 4 filing by Forbes Kendall, Executive Vice President, Sales & Operations of Guardian Pharmacy Services, Inc. (GRDN). The filing reports that on 09/27/2025 the reporting person had a transaction converting 608,570 shares into Class A Common Stock (transaction code M). After the reported transaction, the reporting person beneficially owned 812,476 shares of Class A common stock according to Table I. Table II shows the corresponding Class B common stock conversion of 608,570 shares, resulting in aggregate beneficial ownership of 1,217,140 shares of Class A common stock following the conversion. The filing notes these Class B shares convert into Class A shares on a one-for-one basis in substantially equal tranches on 09/27/2025, 03/28/2026 and 09/27/2026. The form is signed by an attorney-in-fact on behalf of the reporting person on 09/30/2025.
Cardinal Equity Fund, L.P. reported changes in beneficial ownership of Guardian Pharmacy Services, Inc. (GRDN). The filing shows sales of Class A common stock on May 27, 2025 (270,958 shares at $20.16) and May 28, 2025 (50,305 shares at $20.16), executed pursuant to an Underwriting Agreement dated May 22, 2025. After those disposals the filing shows beneficial ownership of 149,794 and 200,099 shares following each reported sale. The reporting person also holds Class B common stock that will automatically convert one-for-one into Class A shares in substantially equal tranches on September 27, 2025, March 28, 2026 and September 27, 2026, with a tranche of 471,057 shares converting on September 27, 2025, resulting in 620,851 Class A shares reported as beneficially owned after that conversion tranche.
Bindley Capital Partners I, LLC, a director-level reporting person of Guardian Pharmacy Services, Inc. (GRDN), reported a non‑derivative transaction dated 09/27/2025 converting 6,100,176 shares of Class B common stock into 6,100,176 shares of Class A common stock under the issuer's amended certificate of incorporation. After the conversion, the reporting person beneficially owns 8,039,993 shares of Class A common stock and, counting derivative holdings, 12,200,350 total shares beneficially owned. The filing is signed by an attorney‑in‑fact on 09/30/2025.
Thomas J. Salentine Jr., a director and reported >10% owner of Guardian Pharmacy Services, Inc. (GRDN), reported a Section 16 transaction on Form 4 showing activity on 09/27/2025. The filing discloses 6,100,176 shares of Class A common stock acquired (code M) and a disposition of 35,714 Class A shares. After the reported non-derivative transaction the filing shows 8,039,993 Class A shares beneficially owned indirectly through Bindley Capital Partners I, LLC. The filing also reports converted derivative/Class B activity reflecting 6,100,176 Class B shares treated as converted into Class A, bringing total indirect beneficial ownership of Class A to 12,200,350 shares. The filing notes these Class B shares convert one-for-one in tranches on 09/27/2025, 03/28/2026 and 09/27/2026.
Guardian Pharmacy Services insider David K. Morris, an executive vice president and CFO, reported conversion and transfer-related changes in his holdings. On 09/27/2025, 641,869 shares of Class B common stock were reported as converted into Class A common stock on a one-for-one basis, increasing his reported Class A beneficial ownership to 856,364 shares. The filing explains that Class B shares convert in substantially equal tranches on 09/27/2025, 03/28/2026 and 09/27/2026. Under a September 2025 domestic relations order, Morris agreed to transfer 422,989 Class A shares by 11/11/2025 and an additional 641,870 Class A shares between 03/28/2026 and 11/11/2026.
Guardian Pharmacy Services insider conversion increased reported Class A holdings. On 09/27/2025 William E. Bindley, a director and 10% owner, reported the conversion of 6,100,176 shares into Class A common stock. After the conversion, the filing shows 8,039,993 shares of Class A beneficially owned (indirectly) by Bindley and, including derivative/underlying shares, a total of 12,200,350 shares reported as beneficially owned indirectly by Bindley Capital Partners I, LLC. The filing states these Class B shares convert one-for-one into Class A in substantially equal tranches on 09/27/2025, 03/28/2026 and 09/27/2026.
Pharmacy Investors, LLC reported changes in its beneficial ownership of Guardian Pharmacy Services, Inc. (GRDN). The reporting person sold a total of 964,316 shares of Class A common stock in two transactions on May 27, 2025 (813,318 shares) and May 28, 2025 (150,998 shares) at $20.16 per share under an underwriting agreement.
The filing also shows a merger/conversion event: 1,413,940 shares of Class B common stock are scheduled to convert into Class A common stock on September 27, 2025 (part of staggered tranches with later conversions in March and September 2026). After the reported transactions and recognizing the conversion tranche, the reporting person beneficially owns 1,863,564 Class A shares (direct) and, counting derivative holdings, a total of 2,827,878 shares shown as beneficially owned following the transactions.
Insider conversion of Class B to Class A shares recorded for Guardian Pharmacy Services, Inc. (GRDN). The reporting person, Fred Burke, submitted a Form 4 showing a transaction dated 09/27/2025 in which 1,298,826 shares were reported under transaction code "M" as acquired. Per the filing, Burke's Class B common stock automatically converts one-for-one into Class A common stock in substantially equal tranches on 09/27/2025, 03/28/2026 and 09/27/2026. After the reported conversion, Burke beneficially owned 2,597,651 shares of Class A common stock. The filing identifies Burke as a Director and as President and Chief Executive Officer; the Form 4 was signed by an attorney-in-fact on 09/30/2025.
Cardinal Equity Fund, L.P. filed an initial Form 3 reporting beneficial ownership in Guardian Pharmacy Services, Inc. (GRDN). The filing shows 471,057 shares of Class A common stock held directly and that 1,413,171 additional Class A shares are attributable to Class B common stock that converts one-for-one in four substantially equal tranches, with the first conversion occurring on 03/28/2025 and remaining dates on 09/27/2025, 03/28/2026 and 09/27/2026. The Form 3 is signed by an attorney-in-fact on behalf of the reporting person.
FAQ
What is the current stock price of Guardian Pharmacy Services (GRDN)?
What is the market cap of Guardian Pharmacy Services (GRDN)?
